Cypress Capital’s Medtronic MDT Stock Holding History

Cypress Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.61M	Buy	30,258 +921	+3%	+$81.2K	0.69%	33
2026 Q2	$2.3M	Sell	29,337 -679	-2%	-$54.8K	0.62%	38
2026 Q1	$2.6M	Sell	30,016 -256	-0.8%	-$24.5K	0.74%	30
2025 Q4	$2.91M	Buy	30,272 +660	+2%	+$64.1K	0.81%	22
2025 Q3	$2.82M	Sell	29,612 -857	-3%	-$78.8K	0.81%	22
2025 Q2	$2.66M	Buy	30,469 +11,684	+62%	+$991K	0.77%	24
2025 Q1	$1.69M	Buy	+18,785	New	+$1.68M	0.49%	40

Other funds holding MDT

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

Cypress Capital's MDT Position: Q3 2026 in Review

Cypress Capital increased its Medtronic (MDT) stake by 3.1% in Q3 2026, buying an estimated $81.2K and bringing the position to 30,258 shares worth $2.61M. The position accounts for 0.69% of the portfolio, ranked #33.

Cypress Capital first reported a position in MDT in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.91M in Q4 2025. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

Cypress Capital held 30,258 shares of Medtronic worth $2.61M as of Q3 2026.
Cypress Capital bought 921 Medtronic shares in Q3 2026, an estimated $81.2K.
Medtronic made up 0.69% of Cypress Capital's portfolio in Q3 2026, its #33 holding.
Cypress Capital first reported a position in Medtronic in Q1 2025 and has held it in 7 quarters since.
Cypress Capital's Medtronic position peaked at $2.91M in Q4 2025.
644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Cypress Capital's 13F filing for Q3 2026, filed 20 Oct 2026.